Conference Coverage
Conference Coverage
Precision CAD testing shows 70% cut in composite risk at 1 year
A streamlined protocol for evaluating suspected stable chest pain substantially improved outcomes at 1 year in the PRECISE trial.
Conference Coverage
Avoid routine early ECMO in severe cardiogenic shock: ECMO-CS
Early ECMO in this setting is increasingly common, but it didn’t seem to improve outcomes in the trial, compared with a more conservative approach...
Conference Coverage
No survival advantage for either torsemide or furosemide in HF: TRANSFORM-HF
One loop diuretic is the most widely used in heart failure, the other may have advantages in some situations, but there’s been no head-to-head...
Conference Coverage
Acute heart failure risk assessment in ED improves outcomes: COACH
Systematic risk assessment of patients with acute heart failure in the ED significantly cut their 30-day and 20-month cardiovascular...
Conference Coverage
Puzzling, unique ECG from pig-to-human transplanted heart
The postimplantation electrocardiogram from the first pig heart xenotransplantation resembled neither a pig nor a human ECG, with unknown...
Conference Coverage
Diuretic agents equal to prevent CV events in hypertension: DCP
Cardiovascular events were nearly identical with two different hypertension drugs in the randomized Diuretic Comparison Project trial.
Conference Coverage
Triglyceride-lowering fails to show CV benefit in large fibrate trial
In the phase 3 PROMINENT trial, pemafibrate improved multiple lipid fractions in patients with type 2 diabetes, without any impact on...
Conference Coverage
Pulmonologist consult at COPD admission reduces risk of return
“When stratified by severity of COPD at the time of admission, the difference in the readmission rate was even greater.”
Conference Coverage
Sexual activities in seniors: Experts advise on what to ask
Failing to address human sexuality in old age can lead doctors to ask seniors the wrong questions about sex.
Conference Coverage
New research confirms recommendations on COVID-19 boosters in MS
“Even MS patients whose B cells were depleted from circulation with ocrelizumab can mount immune responses to COVID-19 vaccines.”